Reverse Transcriptase News and Research

RSS

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Researchers determined the analytical sensitivity of a CE-marked fast antigen with the SARS-CoV-2 Omicron, Delta, Alpha, and Gamma variants.

31 Jan 2022

Escape from vaccine-induced immunity likely contributed to rapid rise of SARS-CoV-2 Omicron

Researchers investigate whether the SARS-CoV-2 Omicron variant is more likely to infect vaccinated individuals than the SARS-CoV-2 Delta variant.

30 Jan 2022

Adults and children have similar neutralizing antibody responses to SARS-CoV-2 infection

Researchers describe the kinetics of SARS-CoV-2-specific serum antibodies in convalescent children over six months following infection.

30 Jan 2022

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Researchers discuss the contributions that have been provided by magnetic nanoparticles for the molecular diagnosis of human viruses.

28 Jan 2022

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

The researchers described COV50, a urinary biomarker, that can predict death and disease progression in COVID-19.

26 Jan 2022

T-cell apoptosis linked to poor prognosis among COVID-19 patients

Researchers assess the probability of T-cell apoptosis in patients with severe COVID-19 who were admitted to the hospital.

26 Jan 2022

Growth advantage of SARS-CoV-2 Omicron variant found to be partly due to shorter serial interval

In a new study, a team of researchers assessed how serial intervals of SARS-CoV-2 Omicron and Delta variants varied during the same time period in the Netherlands.

25 Jan 2022

Neurological complications of the SARS-CoV-2 vaccine

In a study published in the latest issue of the journal Neurological Sciences, a team of researchers described a three-patient case series presenting with neurological manifestations after the coronavirus disease 2019 (COVID-19) vaccination, followed by a literature review, to propose hypotheses on how neurological symptoms might develop after vaccination.

24 Jan 2022

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

In a recent study posted to the Preprints with The Lancet* server, a large team of researchers estimated the comparative risk of hospitalization after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and Delta variants of concern (VOCs) in Denmark.

24 Jan 2022

Human endogenous retrovirus type W envelope protein found to be a biomarker of COVID-19 severity

A new study revealed that the expression of HERV-W envelope protein (ENV) in lymphoid cells from COVID-19 patients correlated with disease outcome making them biomarkers of lymphocyte exhaustion.

24 Jan 2022

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

Researchers assess the impact of the SARS-CoV-2 Omicron variant of concern on symptoms of SARS-CoV-2 infection.

23 Jan 2022

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

In this study, the researchers not only elucidate the recent bioconjugated nanomaterials for targeted diagnosis of SARS-CoV-2, but they also provide the rationale behind these developments by discussing the mechanisms and approaches.

18 Jan 2022

Study suggests vaccinated Omicron cases are unlikely to shed infectious virus 10 days after diagnosis or symptom onset

Researchers have been investigating the Omicron epidemic in Japan and have recently released an early report on the infectious period of the disease.

17 Jan 2022

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient conditions within wastewater infrastructure to understand how it impacts RNA measurements and the related wastewater epidemiology.

11 Jan 2022

Reinfection with SARS-CoV-2 in children

These findings bear out earlier reports that COVID-19 is less frequent and severe in children than adults.

7 Jan 2022

SARS-CoV-2 Omicron less pathogenic in hamsters

A new research paper posted as a preprint to the bioRxiv* server attempts to throw some light on this question by studying viral pathogenicity in golden hamsters, a valuable model for severe COVID-19 due to the development of reproducible weight loss and pneumonia after infection with the virus.

6 Jan 2022

Reverse Transcriptase News and Research

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Escape from vaccine-induced immunity likely contributed to rapid rise of SARS-CoV-2 Omicron

Adults and children have similar neutralizing antibody responses to SARS-CoV-2 infection

Magnetic nanoparticles for SARS-CoV-2 and other virus detection systems

Urinary proteomic COV50 marker accurately predicts adverse COVID-19 outcomes

T-cell apoptosis linked to poor prognosis among COVID-19 patients

Growth advantage of SARS-CoV-2 Omicron variant found to be partly due to shorter serial interval

Neurological complications of the SARS-CoV-2 vaccine

Danish study shows lower risk of hospitalization in Omicron cases compared to Delta

Human endogenous retrovirus type W envelope protein found to be a biomarker of COVID-19 severity

SARS-CoV-2 Omicron associated with fewer lower and more upper respiratory tract symptoms

A novel assay for the rapid detection of SARS-CoV-2 variants

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Study suggests vaccinated Omicron cases are unlikely to shed infectious virus 10 days after diagnosis or symptom onset

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

Reinfection with SARS-CoV-2 in children

SARS-CoV-2 Omicron less pathogenic in hamsters

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

How effective are COVID-19 vaccines against the Omicron and Delta variants?

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News